Hypera S.A. (OTCMKTS:HYPMY – Get Free Report)’s share price reached a new 52-week low during trading on Wednesday . The stock traded as low as $2.64 and last traded at $2.70, with a volume of 10164 shares changing hands. The stock had previously closed at $2.88.
Hypera Stock Performance
The company has a market capitalization of $1.68 billion, a PE ratio of 5.62 and a beta of 1.02. The company has a 50 day moving average price of $3.83 and a 200 day moving average price of $4.73.
Hypera Company Profile
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
See Also
- Five stocks we like better than Hypera
- What Are the FAANG Stocks and Are They Good Investments?
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- Why Are Stock Sectors Important to Successful Investing?
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- 3 Warren Buffett Stocks to Buy Now
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
